The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
Chronic myeloid leukemia: mechanisms of blastic transformation
Open accessAbstract
The BCR-ABL1 oncoprotein transforms pluripotent HSCs and initiates chronic myeloid leukemia (CML). Patients with early phase (also known as chronic phase [CP]) disease usually respond to treatment with ABL tyrosine kinase inhibitors (TKIs), although some patients who respond initially later become resistant. In most patients, TKIs reduce the leukemia cell load substantially, but the cells from which the leukemia cells are derived during CP (so-called leukemia stem cells [LSCs]) are intrinsically insensitive to TKIs and survive long term. LSCs or their progeny can acquire additional genetic and/or epigenetic changes that cause the leukemia to transform from CP to a more advanced phase, which has been subclassified as either accelerated phase or blastic phase disease. The latter responds poorly to treatment and is usually fatal. Here, we discuss what is known about the molecular mechanisms leading to blastic transformation of CML and propose some novel therapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bonnet, D., & Dick, J. E. (1997) · Nature Medicine · doi:10.1038/nm0797-730 · Cited by 5,864
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783
Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia
Druker, B. J., Guilhot, F., O'Brien, S. G., Gathmann, I., Kantarjian, H., Gattermann, N., Deininger, M. W. N., Silver, R. T., Goldman, J. M., Stone, R. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062867 · Cited by 3,488
Self-citationClinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification
Gorre, M. E., Mohammed, M., Ellwood, K., Hsu, N., Paquette, R., Rao, P. N., & Sawyers, C. L. (2001) · Science · doi:10.1126/science.1062538 · Cited by 3,104
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
Jamieson, C. H. M., Ailles, L. E., Dylla, S. J., Muijtjens, M., Jones, C., Zehnder, J. L., Gotlib, J., Li, K., Manz, M. G., Keating, A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040258 · Cited by 1,485
Baccarani, M. (2006) · Blood · doi:10.1182/blood-2006-02-005686 · Cited by 1,277
Graham, S. M., Jørgensen, H. G., Allan, E., Pearson, C., Alcorn, M. J., Richmond, L., & Holyoake, T. L. (2002) · Blood · doi:10.1182/blood.v99.1.319 · Cited by 1,181
BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros
Mullighan, C. G., Miller, C. B., Radtke, I., Phillips, L. A., Dalton, J., Ma, J., White, D., Hughes, T. P., Le Beau, M. M., Pui, C.-H., et al. (2008) · Nature · doi:10.1038/nature06866 · Cited by 1,072
Beckman, K. B., & Ames, B. N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.32.19633 · Cited by 951
Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia
Zhao, C., Chen, A., Jamieson, C. H., Fereshteh, M., Abrahamsson, A., Blum, J., Kwon, H. Y., Kim, J., Chute, J. P., Rizzieri, D., et al. (2009) · Nature · doi:10.1038/nature07737 · Cited by 869
Self-citationHochhaus, A., O'Brien, S. G., Guilhot, F., Druker, B. J., Branford, S., Foroni, L., Goldman, J. M., Müller, M. C., Radich, J. P., Rudoltz, M., et al. (2009) · Leukemia · doi:10.1038/leu.2009.38 · Cited by 856
Self-citationHuntly, B. J. P., Shigematsu, H., Deguchi, K., Lee, B. H., Mizuno, S., Duclos, N., Rowan, R., Amaral, S., Curley, D., Williams, I. R., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.10.015 · Cited by 697
CIP2A inhibits PP2A in human malignancies
Junttila, M. R., Puustinen, P., Niemelä, M., Ahola, R., Arnold, H., Böttzauw, T., Ala-aho, R., Nielsen, C., Ivaska, J., Taya, Y., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.044 · Cited by 677
Donato, N. J., Wu, J. Y., Stapley, J., Gallick, G., Lin, H., Arlinghaus, R., & Talpaz, M. (2003) · Blood · doi:10.1182/blood.v101.2.690 · Cited by 663
Cozzio, A., Passegué, E., Ayton, P. M., Karsunky, H., Cleary, M. L., & Weissman, I. L. (2003) · Genes & Development · doi:10.1101/gad.1143403 · Cited by 663
Part I: Mechanisms of resistance to imatinib in chronic myeloid leukaemia
Apperley, J. F. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70342-x · Cited by 643
Chronic myeloid leukaemia as a model of disease evolution in human cancer
Melo, J. V., & Barnes, D. J. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2147 · Cited by 623
Loss of β-Catenin Impairs the Renewal of Normal and CML Stem Cells In Vivo
Zhao, C., Blum, J., Chen, A., Kwon, H. Y., Jung, S. H., Cook, J. M., Lagoo, A., & Reya, T. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.11.003 · Cited by 592
The biology of CML blast crisis
Calabretta, B., & Perrotti, D. (2004) · Blood · doi:10.1182/blood-2003-12-4111 · Cited by 592
Self-citationGene expression changes associated with progression and response in chronic myeloid leukemia
Radich, J. P., Dai, H., Mao, M., Oehler, V., Schelter, J., Druker, B., Sawyers, C., Shah, N., Stock, W., Willman, C. L., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510423103 · Cited by 583
Bellodi, C., Lidonnici, M. R., Hamilton, A., Helgason, G. V., Soliera, A. R., Ronchetti, M., Galavotti, S., Young, K. W., Selmi, T., Yacobi, R., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci35660 · Cited by 570
Eiring, A. M., Harb, J. G., Neviani, P., Garton, C., Oaks, J. J., Spizzo, R., Liu, S., Schwind, S., Santhanam, R., Hickey, C. J., et al. (2010) · Cell · doi:10.1016/j.cell.2010.01.007 · Cited by 560
Self-citationPML targeting eradicates quiescent leukaemia-initiating cells
Ito, K., Bernardi, R., Morotti, A., Matsuoka, S., Saglio, G., Ikeda, Y., Rosenblatt, J., Avigan, D. E., Teruya-Feldstein, J., & Pandolfi, P. P. (2008) · Nature · doi:10.1038/nature07016 · Cited by 538
Bernstein, C. (2002) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(02)00009-1 · Cited by 527
Expansion of Bcr-Abl-Positive Leukemic Stem Cells Is Dependent on Hedgehog Pathway Activation
Dierks, C., Beigi, R., Guo, G.-R., Zirlik, K., Stegert, M. R., Manley, P., Trussell, C., Schmitt-Graeff, A., Landwerlin, K., Veelken, H., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.08.003 · Cited by 517
Nakamura, T., Largaespada, D. A., Lee, M. P., Johnson, L. A., Ohyashiki, K., Toyama, K., Chen, S. J., Willman, C. L., Chen, I.-M., Feinberg, A. P., et al. (1996) · Nature Genetics · doi:10.1038/ng0296-154 · Cited by 493
le Coutre, P., Tassi, E., Varella-Garcia, M., Barni, R., Mologni, L., Cabrita, G., Marchesi, E., Supino, R., & Gambacorti-Passerini, C. (2000) · Blood · doi:10.1182/blood.v95.5.1758.005a41_1758_1766 · Cited by 484
Neviani, P., Santhanam, R., Trotta, R., Notari, M., Blaser, B. W., Liu, S., Mao, H., Chang, J. S., Galietta, A., Uttam, A., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.015 · Cited by 476
Self-citationGenetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression
Bueno, M. J., Pérez de Castro, I., Gómez de Cedrón, M., Santos, J., Calin, G. A., Cigudosa, J. C., Croce, C. M., Fernández-Piqueras, J., & Malumbres, M. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.03.013 · Cited by 467
Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression
Bueno, M. J., Pérez de Castro, I., Gómez de Cedrón, M., Santos, J., Calin, G. A., Cigudosa, J. C., Croce, C. M., Fernández-Piqueras, J., & Malumbres, M. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.04.018 · Cited by 457
Cytogenetic and Molecular Genetic Evolution of Chronic Myeloid Leukemia
Johansson, B., Fioretos, T., & Mitelman, F. (2002) · Acta Haematologica · doi:10.1159/000046636 · Cited by 454
Soverini, S., Martinelli, G., Rosti, G., Bassi, S., Amabile, M., Poerio, A., Giannini, B., Trabacchi, E., Castagnetti, F., Testoni, N., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.531 · Cited by 374
Jiang, X., Zhao, Y., Smith, C., Gasparetto, M., Turhan, A., Eaves, A., & Eaves, C. (2007) · Leukemia · doi:10.1038/sj.leu.2404609 · Cited by 359
Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells
Venturini, L., Battmer, K., Castoldi, M., Schultheis, B., Hochhaus, A., Muckenthaler, M. U., Ganser, A., Eder, M., & Scherr, M. (2007) · Blood · doi:10.1182/blood-2006-09-045104 · Cited by 353
Neviani, P., Santhanam, R., Oaks, J. J., Eiring, A. M., Notari, M., Blaser, B. W., Liu, S., Trotta, R., Muthusamy, N., Gambacorti-Passerini, C., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31095 · Cited by 335
Self-citationMitani, K., Ogawa, S., Tanaka, T., Miyoshi, H., Kurokawa, M., Mano, H., Yazaki, Y., Ohki, M., & Hirai, H. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06288.x · Cited by 325
BCR/ABL Regulates Mammalian RecA Homologs, Resulting in Drug Resistance
Slupianek, A., Schmutte, C., Tombline, G., Nieborowska-Skorska, M., Hoser, G., Nowicki, M. O., Pierce, A. J., Fishel, R., & Skorski, T. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00357-4 · Cited by 314
Self-citationBCR-ABL suppresses C/EBPα expression through inhibitory action of hnRNP E2
Perrotti, D., Cesi, V., Trotta, R., Guerzoni, C., Santilli, G., Campbell, K., Iervolino, A., Condorelli, F., Gambacorti-Passerini, C., Caligiuri, M. A., et al. (2002) · Nature Genetics · doi:10.1038/ng791 · Cited by 313
Self-citationJørgensen, H. G., Allan, E. K., Jordanides, N. E., Mountford, J. C., & Holyoake, T. L. (2007) · Blood · doi:10.1182/blood-2006-11-057521 · Cited by 306
Willis, S. G., Lange, T., Demehri, S., Otto, S., Crossman, L., Niederwieser, D., Stoffregen, E. P., McWeeney, S., Kovacs, I., Park, B., et al. (2005) · Blood · doi:10.1182/blood-2005-03-1036 · Cited by 302
BCR/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance
Koptyra, M., Falinski, R., Nowicki, M. O., Stoklosa, T., Majsterek, I., Nieborowska-Skorska, M., Blasiak, J., & Skorski, T. (2006) · Blood · doi:10.1182/blood-2005-07-2815 · Cited by 298
Self-citationCortes, J., Jabbour, E., Kantarjian, H., Yin, C. C., Shan, J., O'Brien, S., Garcia-Manero, G., Giles, F., Breeden, M., Reeves, N., et al. (2007) · Blood · doi:10.1182/blood-2007-03-080838 · Cited by 296
Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia
Chen, Y., Hu, Y., Zhang, H., Peng, C., & Li, S. (2009) · Nature Genetics · doi:10.1038/ng.389 · Cited by 293
Gratwohl, A. A., Brand, R., Apperley, J. F., Crawley, C. R., Ruutu, T., Corradini, P., Carreras, E., Devergié, A., Guglielmi, C., Kölb, H.-J., et al. (2006) · PubMed · Cited by 290
Nowicki, M. O., Falinski, R., Koptyra, M., Slupianek, A., Stoklosa, T., Gloc, E., Nieborowska-Skorska, M., Blasiak, J., & Skorski, T. (2004) · Blood · doi:10.1182/blood-2004-05-1941 · Cited by 278
Glycogen synthase kinase 3β missplicing contributes to leukemia stem cell generation
Abrahamsson, A. E., Geron, I., Gotlib, J., Dao, K.-H. T., Barroga, C. F., Newton, I. G., Giles, F. J., Durocher, J., Creusot, R. S., Karimi, M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900189106 · Cited by 246
Self-citationLahaye, T., Riehm, B., Berger, U., Paschka, P., Müller, M. C., Kreil, S., Merx, K., Schwindel, U., Schoch, C., Hehlmann, R., et al. (2005) · Cancer · doi:10.1002/cncr.20922 · Cited by 232
Shah, N. P., Kasap, C., Weier, C., Balbas, M., Nicoll, J. M., Bleickardt, E., Nicaise, C., & Sawyers, C. L. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.11.001 · Cited by 230
The function of the protein tyrosine phosphatase SHP-1 in cancer
Wu, C. (2003) · Gene · doi:10.1016/s0378-1119(03)00400-1 · Cited by 225
Bcr‐Abl stabilizes β‐catenin in chronic myeloid leukemia through its tyrosine phosphorylation
Coluccia, A. M. L., Vacca, A., Duñach, M., Mologni, L., Redaelli, S., Bustos, V. H., Benati, D., Pinna, L. A., & Gambacorti‐Passerini, C. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601485 · Cited by 217
BCR/ABL activates mdm2 mRNA translation via the La antigen
Trotta, R., Vignudelli, T., Candini, O., Intine, R. V., Pecorari, L., Guerzoni, C., Santilli, G., Byrom, M. W., Goldoni, S., Ford, L. P., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00020-5 · Cited by 217
Self-citationA murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9
Dash, A. B., Williams, I. R., Kutok, J. L., Tomasson, M. H., Anastasiadou, E., Lindahl, K., Li, S., Van Etten, R. A., Borrow, J., Housman, D., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102583199 · Cited by 209
Agirre, X., Jiménez-Velasco, A., San José-Enériz, E., Garate, L., Bandrés, E., Cordeu, L., Aparicio, O., Saez, B., Navarro, G., Vilas-Zornoza, A., et al. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0167 · Cited by 205
A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation
Notari, M., Neviani, P., Santhanam, R., Blaser, B. W., Chang, J.-S., Galietta, A., Willis, A. E., Roy, D. C., Caligiuri, M. A., Marcucci, G., et al. (2006) · Blood · doi:10.1182/blood-2005-09-3732 · Cited by 202
Self-citationGriswold, I. J., MacPartlin, M., Bumm, T., Goss, V. L., O'Hare, T., Lee, K. A., Corbin, A. S., Stoffregen, E. P., Smith, C., Johnson, K., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02202-05 · Cited by 200
Barnes, D. J., Palaiologou, D., Panousopoulou, E., Schultheis, B., Yong, A. S. M., Wong, A., Pattacini, L., Goldman, J. M., & Melo, J. V. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0076 · Cited by 200
Self-citationSill, H., Goldman, J., & Cross, N. (1995) · Blood · doi:10.1182/blood.v85.8.2013.bloodjournal8582013 · Cited by 197
Self-citationWilliams, R. T., Roussel, M. F., & Sherr, C. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602030103 · Cited by 193
Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia
Zhang, S.-J., Ma, L.-Y., Huang, Q.-H., Li, G., Gu, B.-W., Gao, X.-D., Shi, J.-Y., Wang, Y.-Y., Gao, L., Cai, X., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711824105 · Cited by 181
Hofmann, I., Stover, E. H., Cullen, D. E., Mao, J., Morgan, K. J., Lee, B. H., Kharas, M. G., Miller, P. G., Cornejo, M. G., Okabe, R., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.03.016 · Cited by 177
Roles of Bim in Apoptosis of Normal and Bcr-Abl-Expressing Hematopoietic Progenitors
Kuribara, R., Honda, H., Matsui, H., Shinjyo, T., Inukai, T., Sugita, K., Nakazawa, S., Hirai, H., Ozawa, K., & Inaba, T. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.14.6172-6183.2004 · Cited by 167
Chu, S., Holtz, M., Gupta, M., & Bhatia, R. (2004) · Blood · doi:10.1182/blood-2003-04-1271 · Cited by 163
Klemm, L., Duy, C., Iacobucci, I., Kuchen, S., von Levetzow, G., Feldhahn, N., Henke, N., Li, Z., Hoffmann, T. K., Kim, Y.-M., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.07.030 · Cited by 162
Expression of BCR/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias
Jaiswal, S., Traver, D., Miyamoto, T., Akashi, K., Lagasse, E., & Weissman, I. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1633833100 · Cited by 161
Gaiger, A., Henn, T., Horth, E., Geissler, K., Mitterbauer, G., Maier-Dobersberger, T., Greinix, H., Mannhalter, C., Haas, O., & Lechner, K. (1995) · Blood · doi:10.1182/blood.v86.6.2371.bloodjournal8662371 · Cited by 160
Santaguida, M. A., Schepers, K., King, B., Sabnis, A. J., Forsberg, E. C., Attema, J. L., Braun, B. S., & Passegue, E. A. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.02.016 · Cited by 159
Sallmyr, A., Tomkinson, A. E., & Rassool, F. V. (2008) · Blood · doi:10.1182/blood-2007-07-104257 · Cited by 158
Phosphorylation of C/EBPα Inhibits Granulopoiesis
Ross, S. E., Radomska, H. S., Wu, B., Zhang, P., Winnay, J. N., Bajnok, L., Hahn, W. S., Schaufele, F., Tenen, D. G., & MacDougald, O. A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.24.2.675-686.2004 · Cited by 152
Chronic Myeloid Leukemia Stem Cells
Kavalerchik, E., Goff, D. J., & Jamieson, C. H. M. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.5745 · Cited by 148
Self-citationPunish the parent not the progeny
Elrick, L. J., Jørgensen, H. G., Mountford, J. C., & Holyoake, T. L. (2004) · Blood · doi:10.1182/blood-2004-08-3373 · Cited by 148
Jabbour, E. J., Kantarjian, H. M., Abruzzo, L. V., O'Brien, S. M., Garcia‐Manero, G., Verstovšek, S., Shan, J., Rios, M. B., & Cortes, J. E. (2007) · Blood · doi:10.1182/blood-2007-01-070045 · Cited by 146
Instability of BCR-ABL Gene in Primary and Cultured Chronic Myeloid Leukemia Stem Cells
Jiang, X., Saw, K. M., Eaves, A. C., & Eaves, C. J. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk150 · Cited by 138
Samanta, A. K., Chakraborty, S. N., Wang, Y., Kantarjian, H. M., Sun, X., Hood, J. D., Perrotti, D., & Arlinghaus, R. B. (2009) · Oncogene · doi:10.1038/onc.2009.7 · Cited by 127
Self-citationLoss of p53 impedes the antileukemic response to BCR-ABL inhibition
Wendel, H., de Stanchina, E., Cepero, E., Ray, S., Emig, M., Fridman, J. S., Veach, D. R., Bornmann, W. G., Clarkson, B. D., McCombie, W. R., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602402103 · Cited by 127
Blast crisis of chronic granulocytic leukemia
Rosenthal, S. N., Canellos, G. P., Whang‐Peng, J., & Gralnick, H. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90199-1 · Cited by 126
Iervolino, A., Santilli, G., Trotta, R., Guerzoni, C., Cesi, V., Bergamaschi, A., Gambacorti-Passerini, C. B., Calabretta, B., & Perrotti, D. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.7.2255-2266.2002 · Cited by 122
Self-citationCopland, M., Pellicano, F., Richmond, L., Allan, E. K., Hamilton, A., Lee, F. Y., Weinmann, R. S., & Holyoake, T. L. (2007) · Blood · doi:10.1182/blood-2007-09-112573 · Cited by 121
Nakayama, H., Ishimaru, F., Avitahl, N., Sezaki, N., Fujii, N., Nakase, K., Ninomiya, Y., Harashima, A., Minowada, J., Tsuchiyama, J., et al. (1999) · PubMed · Cited by 118
Protein phosphatase 2A (PP2A), a drugable tumor suppressor in Ph1(+) leukemias
Perrotti, D., & Neviani, P. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9119-x · Cited by 117
Self-citationBarnes, D. J., & Melo, J. V. (2006) · Cell Cycle · doi:10.4161/cc.5.24.3573 · Cited by 117
The derivation of diagnostic markers of chronic myeloid leukemia progression from microarray data.
Oehler, V., Yeung, K., Choi, Y. E., Bumgarner, R. E., Raftery, A., & Radich, J. (2009) · Blood · doi:10.1182/blood-2009-03-212969 · Cited by 115
Iacobucci, I., Lonetti, A., Messa, F., Cilloni, D., Arruga, F., Ottaviani, E., Paolini, S., Papayannidis, C., Piccaluga, P. P., Giannoulia, P., et al. (2008) · Blood · doi:10.1182/blood-2007-09-112631 · Cited by 111
Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens
Fan, A. C., Deb-Basu, D., Orban, M. W., Gotlib, J. R., Natkunam, Y., O’Neill, R. A., Padua, R. A., Xu, L., Taketa, D. A., Shirer, A. E., et al. (2009) · Nature Medicine · doi:10.1038/nm.1903 · Cited by 105
Koenig, H., Copland, M., Chu, S., Jove, R., Holyoake, T. L., & Bhatia, R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1131 · Cited by 101
Chang, J. S., Santhanam, R., Trotta, R., Neviani, P., Eiring, A. M., Briercheck, E. L., Ronchetti, M., Roy, D., Calabretta, B., Caligiuri, M. A., et al. (2007) · Blood · doi:10.1182/blood-2007-03-078303 · Cited by 100
Self-citationBCR/ABL Inhibits Mismatch Repair to Protect from Apoptosis and Induce Point Mutations
Stokłosa, T., Popławski, T., Koptyra, M., Nieborowska-Skorska, M., Basak, G. W., Słupianek, A., Rayevskaya, M., Seferyńska, I., Herrera, L., Błasiak, J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6858 · Cited by 97
Mullighan, C. G., Williams, R. T., Downing, J. R., & Sherr, C. J. (2008) · Genes & Development · doi:10.1101/gad.1673908 · Cited by 96
Cramer, K., Nieborowska-Skorska, M., Koptyra, M., Słupianek, A., Penserga, E. T. P., Eaves, C. J., Aulitzky, W. E., & Skórski, T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1101 · Cited by 96
Clonal evolution in chronic myelogenous leukemia
Cortes, J. E., & O'Dwyer, M. E. (2004) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2004.03.012 · Cited by 94
BCR-ABL-transformed GMP as myeloid leukemic stem cells
Minami, Y., Stuart, S. A., Ikawa, T., Jiang, Y. D., Banno, A., Hunton, I. C., Young, D. J., Naoe, T., Murre, C., Jamieson, C. H. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808303105 · Cited by 93
Self-citationCharacterization of cancer stem cells in chronic myeloid leukaemia
Jørgensen, H. G., & Holyoake, T. L. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351347 · Cited by 93
Role of Dok-1 and Dok-2 in Leukemia Suppression
Niki, M., Cristofano, A. D., Zhao, M., Honda, H., Hirai, H., Aelst, L. V., Cordon‐Cardo, C., & Pandolfi, P. P. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041306 · Cited by 92
Helbling, D., Mueller, B. U., Timchenko, N. A., Hagemeijer, A., Jotterand, M., Meyer‐Monard, S., Lister, A. T., Rowley, J. D., Huegli, B., Fey, M. F., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404731101 · Cited by 89
Guerzoni, C., Bardini, M., Mariani, S. A., Ferrari‐Amorotti, G., Neviani, P., PANNO, M. L., Zhang, Y., Martinez, R., Perrotti, D., & Calabretta, B. (2006) · Blood · doi:10.1182/blood-2005-08-3181 · Cited by 87
Self-citationBlastic transformation of p53-deficient bone marrow cells by p210 bcr/abl tyrosine kinase
Skórski, T., Nieborowska-Skorska, M., Wlodarski, P. K., Perrotti, D., Martinez, R., Wasik, M. A., & Calabretta, B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13137 · Cited by 84
Self-citationp210 BCR/ABL kinase regulates nucleotide excision repair (NER) and resistance to UV radiation
Canitrot, Y., Falinski, R., Louat, T., Laurent, G., Cazaux, C., Hoffmann, J., Lautier, D., & Skórski, T. (2003) · Blood · doi:10.1182/blood-2002-10-3207 · Cited by 83
Oehler, V. G., Guthrie, K. A., Cummings, C. L., Sabo, K. M., Wood, B. L., Gooley, T. A., Yang, T., Epping, M. T., Shou, Y., Pogosova‐Agadjanyan, E. L., et al. (2009) · Blood · doi:10.1182/blood-2008-07-170282 · Cited by 83
Bruns, I., Czibere, A. G., Fischer, J., Roels, F., Cadeddu, R.-P., Buest, S., Brünnert, D., Huenerlituerkoglu, A.-N., Stoecklein, N., Singh, R., et al. (2009) · Leukemia · doi:10.1038/leu.2008.392 · Cited by 82
Roche‐Lestienne, C., Deluche, L., Corm, S., Tigaud, I., Joha, S., Philippe, N., Geffroy, S., Laï, J., Nicolini, F. E., & Preudhomme, C. (2008) · Blood · doi:10.1182/blood-2007-07-102533 · Cited by 80
BCR/ABL promotes accumulation of chromosomal aberrations induced by oxidative and genotoxic stress
Koptyra, M., Cramer, K., Słupianek, A., Richardson, C. A., & Skórski, T. (2008) · Leukemia · doi:10.1038/leu.2008.78 · Cited by 80
Cuenco, G. M., & Ren, R. (2001) · Oncogene · doi:10.1038/sj.onc.1205095 · Cited by 79
BCR/ABL, DNA damage and DNA repair: Implications for new treatment concepts
Skórski, T. (2008) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/03093640701859089 · Cited by 73
Lemoli, R. M., Salvestrini, V., Bianchi, E., Bertolini, F., Fogli, M., Amabile, M., Tafuri, A., Salati, S., Zini, R., Testoni, N., et al. (2009) · Blood · doi:10.1182/blood-2008-08-176016 · Cited by 71
Chronic Myeloid Leukemia Stem Cells
Jamieson, C. H. M. (2008) · Hematology · doi:10.1182/asheducation-2008.1.436 · Cited by 70
Self-citationWagner, K., Zhang, P., Rosenbauer, F., Drescher, B., Kobayashi, S., Radomska, H. S., Kutok, J. L., Gilliland, D. G., Krauter, J., & Tenen, D. G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508143103 · Cited by 66
Lee, T., Ma, W., Zhang, X., Giles, F. J., Cortes, J. E., Kantarjian, H. M., & Albitar, M. X. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0482 · Cited by 66
Rodrigues, M. S., Reddy, M. M., & Sattler, M. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2071 · Cited by 65
Klein, F., Feldhahn, N., Herzog, S., Sprangers, M., Mooster, J. L., Jumaa, H., & Müschen, M. (2005) · Oncogene · doi:10.1038/sj.onc.1209133 · Cited by 64
From mRNA Metabolism to Cancer Therapy: Chronic Myelogenous Leukemia Shows the Way
Perrotti, D., & Neviani, P. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2320 · Cited by 63
Self-citationATR-Chk1 Axis Protects BCR/ABL Leukemia Cells from the Lethal Effect of DNA Double-Strand Breaks
Nieborowska-Skorska, M., Stokłosa, T., Datta, M., Czechowska, A., Rink, L. A., Słupianek, A., Koptyra, M., Seferyńska, I., Krszyna, K., Błasiak, J., et al. (2006) · Cell Cycle · doi:10.4161/cc.5.9.2722 · Cited by 59
Miething, C., Grundler, R., Mugler, C., Brero, S., Hoepfl, J., Geigl, J. B., Speicher, M. R., Ottmann, O. G., Peschel, C., & Duyster, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604716104 · Cited by 53
Salesse, S., Dylla, S. J., & Verfaillie, C. M. (2004) · Leukemia · doi:10.1038/sj.leu.2403310 · Cited by 51
Amin, H. M., Hoshino, K., Yang, H., Lin, Q., Lai, R. L., & Garcia-Manero, G. (2007) · The Journal of Pathology · doi:10.1002/path.2178 · Cited by 49
Genomic profile of chronic myelogenous leukemia: Imbalances associated with disease progression
Brazma, D., Grace, C. D., Howard‐Reeves, J., Melo, J. V., Holyoke, T., Apperley, J. F., & Nacheva, E. P. (2007) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20487 · Cited by 48
Kim, T. D., Türkmen, S., Schwarz, M., Koca, G., Nogai, H., Bommer, C., Dörken, B., Daniel, P., & le Coutre, P. (2009) · Haematologica · doi:10.3324/haematol.2009.014712 · Cited by 46
Fabarius, A. C., Haferlach, C., Muller, M. C., Erben, P., Lahaye, T., Giehl, M., Frank, O., Seifarth, W., Hehlmann, R., & Hochhaus, A. (2007) · Haematologica · doi:10.3324/haematol.11064 · Cited by 45
Schuster, C., Forster, K., Dierks, H., Elsässer, A., Behre, G., Simon, N., Danhauser-Riedl, S., Hallek, M. J., & Warmuth, M. (2002) · Blood · doi:10.1182/blood-2002-01-0043 · Cited by 44
FLT3/ITD Mutation Signaling Includes Suppression of SHP-1
Chen, P., Levis, M. J., Brown, P. A., Kim, K.-T., Allebach, J., & Small, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411974200 · Cited by 44
Kim, D. H., Xu, W., Ma, C., Liu, X., Siminovitch, K., Messner, H. A., & Lipton, J. H. (2009) · Blood · doi:10.1182/blood-2008-07-169110 · Cited by 44
Marega, M., Piazza, R., Pirola, A., Redaelli, S., Mogavero, A., Iacobucci, I., Meneghetti, I., Parma, M., Pogliani, E. M., & Gambacorti-Passerini, C. B. (2010) · Leukemia · doi:10.1038/leu.2010.101 · Cited by 43
Nowak, D., Ogawa, S., Müschen, M., Kato, M., Kawamata, N., Meixel, A., Nowak, V., Kim, H. S., Kang, S. Y., PAQUETTE, R. L., et al. (2009) · Blood · doi:10.1182/blood-2009-03-210377 · Cited by 39
Foroni, L., Gerrard, G., Nna, E. O., Khorashad, J. S., Stevens, D., Swale, B., Milojković, D., Reid, A. G., Goldman, J. M., & Marín, D. (2009) · American Journal of Hematology · doi:10.1002/ajh.21457 · Cited by 39
Self-citationSchultheis, B. S., Szydlo, R., Mahon, F., Apperley, J. F., & Melo, J. V. (2005) · Blood · doi:10.1182/blood-2005-01-0210 · Cited by 38
Leukemogenesis induced by wild-type and STI571-resistant BCR/ABL is potently suppressed by C/EBPα
Ferrari‐Amorotti, G., Keeshan, K., Zattoni, M., Guerzoni, C., Iotti, G., Cattelani, S., Donato, N. J., & Calabretta, B. (2006) · Blood · doi:10.1182/blood-2006-01-011833 · Cited by 35
BCR/ABL induces chromosomal instability after genotoxic stress and alters the cell death threshold
Dierov, J. K., Sanchez, P. V., Burke, B. A., Padilla‐Nash, H. M., Putt, M., Ried, T., & Carroll, M. P. (2008) · Leukemia · doi:10.1038/leu.2008.308 · Cited by 35
Li, M., & Damuni, Z. (1998) · Humana Press eBooks · doi:10.1385/0-89603-468-2:59 · Cited by 35
Role of p53 in leukemogenesis of chronic myeloid leukemia
Lanza, F., & Bi, S. (1995) · Stem Cells · doi:10.1002/stem.5530130416 · Cited by 32
Yamamoto, M., Kakihana, K., Kurosu, T., Murakami, N., & Miura, O. (2005) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2004.06.014 · Cited by 31
The impact of gene profiling in chronic myeloid leukaemia
Yong, A. S. M., & Melo, J. V. (2009) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2009.04.002 · Cited by 27
Cross, N. C. P., Daley, G. Q., Green, A. R., Hughes, T. P., Jamieson, C. H. M., Manley, P. W., Mughal, T. I., Perrotti, D., Radich, J. P., Skoda, R. C., et al. (2008) · Leukemia · doi:10.1038/leu.2008.231 · Cited by 26
Self-citationHaferlach, C., Bacher, U., Schnittger, S., Weiss, T., Kern, W., & Haferlach, T. (2009) · Leukemia · doi:10.1038/leu.2009.222 · Cited by 25
Khorashad, J. S., Melo, V., Fiegler, H., Gerrard, G., Marin, D., Apperley, J. F., Goldman, J. M., Foroni, L., & Reid, A. G. (2008) · Leukemia · doi:10.1038/leu.2008.210 · Cited by 24
Self-citationBrain, J. M., Saksena, A., & Laneuville, P. (2002) · Leukemia Research · doi:10.1016/s0145-2126(01)00181-3 · Cited by 20
Pabst, T., Stillner, E., Neuberg, D. S., Nimer, S. D., Willman, C. L., List, A. F., Melo, J. V., Tenen, D. G., & Mueller, B. U. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06057.x · Cited by 17
Deluche, L., Joha, S., Corm, S., Daudignon, A., Geffroy, S., Quief, S., Villenet, C., Kerckaert, J., Laï, J., Preudhomme, C., et al. (2008) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20611 · Cited by 17
Cited by
The evolving concept of cancer and metastasis stem cells
Baccelli, I., & Trumpp, A. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201202014 · Cited by 412
Protein phosphatase 2A: a target for anticancer therapy
Perrotti, D., & Neviani, P. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70558-2 · Cited by 400
Self-citationZhang, B., Ho, Y. W., Huang, Q., Maeda, T., Lin, A., Lee, S.-U., Hair, A., Holyoake, T. L., Huettner, C., & Bhatia, R. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.018 · Cited by 348
DNA-Damage Response in Tissue-Specific and Cancer Stem Cells
Blanpain, C., Mohrin, M., Sotiropoulou, P. A., & Passegué, E. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2010.12.012 · Cited by 348
Reynaud, D., Pietras, E., Barry-Holson, K., Mir, A., Binnewies, M., Jeanne, M., Sala-Torra, O., Radich, J. P., & Passegué, E. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.10.012 · Cited by 335
Metadata
- Authors
- Perrotti, D., Jamieson, C., Goldman, J., & Skorski, T.
- Venue
- Journal of Clinical Investigation
- Published
- 2010-07-01
- Volume
- 120
- Issue
- 7
- Pages
- 2254-2264
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2054086725
- Cited by
- 397
- References
- 135
- FWCI
- 21.19
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.